Regulation of melanoma malignancy by the RP11-705C15.3/miR-145-5p/NRAS/MAPK signaling axis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5500
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Regulation of melanoma malignancy by the RP11-705C15.3/miR-145-5p/NRAS/MAPK signaling axis ; day:14 ; month:12 ; year:2020 ; pages:1-15
Cancer gene therapy ; (14.12.2020), 1-15
- Creator
-
Chen, Xiang-jun
Liu, Sha
Han, Dong-mei
Han, De-zhi
Sun, Wei-jing
Zhao, Xiao-chun
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41417-020-00274-5
- URN
-
urn:nbn:de:101:1-2021012118060564418496
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chen, Xiang-jun
- Liu, Sha
- Han, Dong-mei
- Han, De-zhi
- Sun, Wei-jing
- Zhao, Xiao-chun
- SpringerLink (Online service)
Other Objects (12)
The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma
MEK targeting in N-RAS mutated metastatic melanoma
STAT3 – the switch of melanoma-associated NRAS mutations
Vulvar melanoma: Rare gynaecological malignancy
Vulvar melanoma: Rare gynaecological malignancy
Combinatorial effects of azacitidine and trametinib on NRAS‐mutated melanoma
Pharmacological targeting of casein kinase 1δ suppresses oncogenic NRAS-driven melanoma
Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic pattern
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma
A novel combination treatment against melanoma with NRAS mutation and therapy resistance
The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma
MEK targeting in N-RAS mutated metastatic melanoma
STAT3 – the switch of melanoma-associated NRAS mutations
Vulvar melanoma: Rare gynaecological malignancy
Vulvar melanoma: Rare gynaecological malignancy
Combinatorial effects of azacitidine and trametinib on NRAS‐mutated melanoma
Pharmacological targeting of casein kinase 1δ suppresses oncogenic NRAS-driven melanoma
Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic pattern
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma
A novel combination treatment against melanoma with NRAS mutation and therapy resistance
The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma
MEK targeting in N-RAS mutated metastatic melanoma
STAT3 – the switch of melanoma-associated NRAS mutations
Vulvar melanoma: Rare gynaecological malignancy
Vulvar melanoma: Rare gynaecological malignancy
Combinatorial effects of azacitidine and trametinib on NRAS‐mutated melanoma
Pharmacological targeting of casein kinase 1δ suppresses oncogenic NRAS-driven melanoma
Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic pattern
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma